{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T02:44:05Z","timestamp":1789785845906,"version":"4.0.1"},"reference-count":85,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","jaad.org","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.jaad.2024.03.008","type":"journal-article","created":{"date-parts":[[2024,3,16]],"date-time":"2024-03-16T21:05:38Z","timestamp":1710623138000},"page":"251.e1-251.e11","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Full Guidelines\u2014From the Medical Board of the National Psoriasis Foundation: Perioperative management of systemic immunomodulatory agents in patients with psoriasis and psoriatic arthritis"],"prefix":"10.1016","volume":"91","author":[{"given":"Warren A.","family":"James","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela L.","family":"Rosenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jashin J.","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvia","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"April","family":"Armstrong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth B.","family":"Wallace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lara Wine","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Merola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Schwartzman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dafna","family":"Gladman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clive","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Koo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason E.","family":"Hawkes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soumya","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ron","family":"Prussick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Yamauchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Lewitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Soung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffery","family":"Weinberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Lebwohl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brad","family":"Glick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leon","family":"Kircik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seemal","family":"Desai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven R.","family":"Feldman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mallory L.","family":"Zaino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2024.03.008_bib1","series-title":"Psoriasis Statistics","year":"2020"},{"issue":"19","key":"10.1016\/j.jaad.2024.03.008_bib2","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1001\/jama.2020.4006","article-title":"Pathophysiology, clinical presentation, and treatment of psoriasis: a review","volume":"323","author":"Armstrong","year":"2020","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.jaad.2024.03.008_bib3","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jaad.2016.07.064","article-title":"Psoriasis and comorbid diseases: epidemiology","volume":"76","author":"Takeshita","year":"2017","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2024.03.008_bib4","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/j.jaad.2016.06.014","article-title":"From the Medical Board of the National Psoriasis Foundation: perioperative management of systemic immunomodulatory agents in patients with psoriasis and psoriatic arthritis","volume":"75","author":"Choi","year":"2016","journal-title":"J Am Acad Dermatol"},{"issue":"7183","key":"10.1016\/j.jaad.2024.03.008_bib5","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1136\/bmj.318.7183.593","article-title":"Clinical guidelines: developing guidelines","volume":"318","author":"Shekelle","year":"1999","journal-title":"BMJ"},{"issue":"22","key":"10.1016\/j.jaad.2024.03.008_bib6","doi-asserted-by":"crossref","first-page":"e77","DOI":"10.1016\/j.jacc.2014.07.944","article-title":"2014 ACC\/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: a report of the American College of Cardiology\/American Heart Association Task Force on practice guidelines","volume":"64","author":"Fleisher","year":"2014","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"10.1016\/j.jaad.2024.03.008_bib66","doi-asserted-by":"crossref","DOI":"10.1001\/jamasurg.2017.1538","article-title":"Association of preoperative anti-tumor necrosis factor therapy with adverse postoperative outcomes in patients undergoing abdominal surgery for ulcerative colitis","volume":"152","author":"Kulaylat","year":"2017","journal-title":"JAMA Surg"},{"issue":"2","key":"10.1016\/j.jaad.2024.03.008_bib67","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1093\/ibd\/izx036","article-title":"Postoperative morbidity risks following ileocolic resection for crohn\u2019s disease treated with anti-tnf alpha therapy: a retrospective study of 360 patients","volume":"24","author":"Jouvin","year":"2018","journal-title":"Inflamm Bowel Dis"},{"issue":"2","key":"10.1016\/j.jaad.2024.03.008_bib68","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1097\/SLA.0000000000002017","article-title":"Anti-TNF therapy is associated with an increased risk of postoperative morbidity after surgery for ileocolonic crohn disease: results of a prospective nationwide cohort","volume":"267","author":"Brouquet","year":"2018","journal-title":"Ann Surg"},{"issue":"11","key":"10.1016\/j.jaad.2024.03.008_bib69","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1097\/DCR.0000000000001467","article-title":"Exposure to anti-tumor necrosis factor medications increases the incidence of pouchitis after restorative proctocolectomy in patients with ulcerative colitis","volume":"62","author":"Bertucci Zoccali","year":"2019","journal-title":"Dis Colon Rectum"},{"issue":"11","key":"10.1016\/j.jaad.2024.03.008_bib70","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1097\/DCR.0000000000001482","article-title":"Biologics and 30-day postoperative complications after abdominal operations for crohn\u2019s disease: are there differences in the safety profiles?","volume":"62","author":"Lightner","year":"2019","journal-title":"Dis Colon Rectum"},{"issue":"9","key":"10.1016\/j.jaad.2024.03.008_bib71","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1093\/ibd\/izz010","article-title":"The influence of preoperative medications on postoperative complications in patients after intestinal surgery for crohn\u2019s disease","volume":"25","author":"Yu","year":"2019","journal-title":"Inflamm Bowel Dis"},{"issue":"4","key":"10.1016\/j.jaad.2024.03.008_bib72","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1007\/s00384-019-03481-1","article-title":"Compare risk factors associated with postoperative infectious complication in Crohn\u2019s disease with and without preoperative infliximab therapy: a cohort study","volume":"35","author":"Tang","year":"2020","journal-title":"Int J Colorectal Dis"},{"issue":"5","key":"10.1016\/j.jaad.2024.03.008_bib73","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1111\/codi.13937","article-title":"Anti-TNF therapy is not associated with an increased risk of post-colectomy complications, a population-based study","volume":"20","author":"Ward","year":"2018","journal-title":"Colorectal Dis"},{"issue":"1","key":"10.1016\/j.jaad.2024.03.008_bib74","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1053\/j.gastro.2022.03.057","article-title":"Prospective cohort study to investigate the safety of preoperative tumor necrosis factor inhibitor exposure in patients with inflammatory bowel disease undergoing intra-abdominal surgery","volume":"163","author":"Cohen","year":"2022","journal-title":"Gastroenterology"},{"issue":"10","key":"10.1016\/j.jaad.2024.03.008_bib75","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1097\/MIB.0000000000000919","article-title":"Preoperative anti-tumor necrosis factor therapy in patients with ulcerative colitis is not associated with an increased risk of infectious and noninfectious complications after ileal pouch-anal anastomosis","volume":"22","author":"Zittan","year":"2016","journal-title":"Inflamm Bowel Dis"},{"issue":"2","key":"10.1016\/j.jaad.2024.03.008_bib76","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1007\/s10620-016-4400-2","article-title":"Tumor necrosis factor alpha inhibitors did not influence postoperative morbidity after elective surgical resections in Crohn\u2019s disease","volume":"62","author":"Kotze","year":"2017","journal-title":"Dig Dis Sci"},{"issue":"6","key":"10.1016\/j.jaad.2024.03.008_bib77","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1093\/ibd\/izab165","article-title":"Peripartum exposure to biologic therapy does not impact postpartum wound healing in women with IBD","volume":"28","author":"Aboubakr","year":"2022","journal-title":"Inflamm Bowel Dis"},{"issue":"10","key":"10.1016\/j.jaad.2024.03.008_bib78","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1097\/DCR.0b013e31829f682c","article-title":"Risk factors for surgical site infection and association with infliximab administration during surgery for Crohn\u2019s disease","volume":"56","author":"Uchino","year":"2013","journal-title":"Dis Colon Rectum"},{"issue":"3","key":"10.1016\/j.jaad.2024.03.008_bib79","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1097\/MPG.0000000000002159","article-title":"The effect of biologics on postoperative complications in children with inflammatory bowel disease and bowel resection","volume":"68","author":"Mitsuya","year":"2019","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"10","key":"10.1016\/j.jaad.2024.03.008_bib80","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1016\/j.jpedsurg.2019.01.006","article-title":"Anti-TNF biologic therapy does not increase postoperative morbidity in pediatric Crohn\u2019s patients","volume":"54","author":"Lightner","year":"2019","journal-title":"J Pediatr Surg"},{"issue":"9","key":"10.1016\/j.jaad.2024.03.008_bib81","doi-asserted-by":"crossref","first-page":"2602","DOI":"10.1007\/s10620-016-4171-9","article-title":"Timing of last preoperative dose of infliximab does not increase postoperative complications in inflammatory bowel disease patients","volume":"61","author":"Alsaleh","year":"2016","journal-title":"Dig Dis Sci"},{"issue":"1","key":"10.1016\/j.jaad.2024.03.008_bib82","doi-asserted-by":"crossref","first-page":"72","DOI":"10.5217\/ir.2020.00117","article-title":"Vedolizumab does not increase perioperative surgical complications in patients with inflammatory bowel disease, cohort study","volume":"20","author":"Poylin","year":"2022","journal-title":"Intest Res"},{"issue":"2","key":"10.1016\/j.jaad.2024.03.008_bib83","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/ajg.2016.541","article-title":"Postoperative complications after ileocecal resection in Crohn\u2019s disease: a prospective study from the REMIND group","volume":"112","author":"Fumery","year":"2017","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"10.1016\/j.jaad.2024.03.008_bib84","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/bjs.9439","article-title":"Complications in surgery for Crohn\u2019s disease after preoperative antitumour necrosis factor therapy","volume":"101","author":"Myrelid","year":"2014","journal-title":"Br J Surg"},{"issue":"9","key":"10.1016\/j.jaad.2024.03.008_bib85","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1007\/s11605-016-3194-z","article-title":"Effect of anti-TNF agents on postoperative outcomes in inflammatory bowel disease patients: a single institution experience","volume":"20","author":"Shwaartz","year":"2016","journal-title":"J Gastrointest Surg"},{"issue":"3","key":"10.1016\/j.jaad.2024.03.008_bib86","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s11605-010-1385-6","article-title":"Preoperative infliximab is not associated with an increased risk of short-term postoperative complications after restorative proctocolectomy and ileal pouch-anal anastomosis","volume":"15","author":"Gainsbury","year":"2011","journal-title":"J Gastrointest Surg"},{"issue":"3","key":"10.1016\/j.jaad.2024.03.008_bib87","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1097\/MPG.0000000000001151","article-title":"Postoperative complications in children with crohn disease treated with infliximab","volume":"63","author":"Zimmerman","year":"2016","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"5","key":"10.1016\/j.jaad.2024.03.008_bib88","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/j.jpedsurg.2016.02.023","article-title":"Evaluating the impact of infliximab use on surgical outcomes in pediatric Crohn\u2019s disease","volume":"51","author":"Abbas","year":"2016","journal-title":"J Pediatr Surg"},{"issue":"1","key":"10.1016\/j.jaad.2024.03.008_bib7","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.ad.2016.08.003","article-title":"Management of biologic therapy in moderate to severe psoriasis in surgical patients: data from the Spanish Biobadaderm Registry","volume":"108","author":"Galiano Mej\u00edas","year":"2017","journal-title":"Actas Dermosifiliogr"},{"issue":"12","key":"10.1016\/j.jaad.2024.03.008_bib8","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1002\/acr.23209","article-title":"Perioperative timing of infliximab and the risk of serious infection after elective hip and knee arthroplasty","volume":"69","author":"George","year":"2017","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"5","key":"10.1016\/j.jaad.2024.03.008_bib9","doi-asserted-by":"crossref","first-page":"495","DOI":"10.3109\/17453674.2013.842431","article-title":"Continuation of TNF blockade in patients with inflammatory rheumatic disease. An observational study on surgical site infections in 1,596 elective orthopedic and hand surgery procedures","volume":"84","author":"Berthold","year":"2013","journal-title":"Acta Orthop"},{"issue":"6","key":"10.1016\/j.jaad.2024.03.008_bib10","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1007\/s00776-011-0142-3","article-title":"Risk of postoperative complications in rheumatoid arthritis relevant to treatment with biologic agents: a report from the Committee on Arthritis of the Japanese Orthopaedic Association","volume":"16","author":"Suzuki","year":"2011","journal-title":"J Orthop Sci"},{"issue":"12","key":"10.1016\/j.jaad.2024.03.008_bib11","doi-asserted-by":"crossref","first-page":"3917","DOI":"10.1093\/rheumatology\/keaa291","article-title":"Pre-operative withholding of infliximab and the risk of infections after major surgery in patients with rheumatoid arthritis","volume":"59","author":"Ward","year":"2020","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"10.1016\/j.jaad.2024.03.008_bib12","doi-asserted-by":"crossref","first-page":"68","DOI":"10.3109\/14397595.2015.1073133","article-title":"Risk factors for surgical site infection and delayed wound healing after orthopedic surgery in rheumatoid arthritis patients","volume":"26","author":"Kadota","year":"2016","journal-title":"Mod Rheumatol"},{"issue":"7","key":"10.1016\/j.jaad.2024.03.008_bib13","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1093\/ecco-jcc\/jjac012","article-title":"Postoperative safety profile of minimally invasive ileocolonic resections for Crohn\u2019s disease in the era of biologic therapy","volume":"16","author":"Abd El Aziz","year":"2022","journal-title":"J Crohns Colitis"},{"issue":"5","key":"10.1016\/j.jaad.2024.03.008_bib14","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1007\/s00384-022-04140-8","article-title":"Association between preoperative biologic use and surgical morbidity in patients with Crohn\u2019s disease","volume":"37","author":"Uchino","year":"2022","journal-title":"Int J Colorectal Dis"},{"issue":"9","key":"10.1016\/j.jaad.2024.03.008_bib15","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1002\/acr.23843","article-title":"Timing of abatacept before elective arthroplasty and risk of postoperative outcomes","volume":"71","author":"George","year":"2019","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"4","key":"10.1016\/j.jaad.2024.03.008_bib16","first-page":"629","article-title":"Safety of surgery in patients with rheumatoid arthritis treated by abatacept: data from the French Orencia in Rheumatoid Arthritis Registry","volume":"56","author":"Latourte","year":"2017","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"10.1016\/j.jaad.2024.03.008_bib17","doi-asserted-by":"crossref","first-page":"502","DOI":"10.3899\/jrheum.181100","article-title":"Does abatacept increase postoperative adverse events in rheumatoid arthritis compared with conventional synthetic disease-modifying drugs?","volume":"47","author":"Ito","year":"2020","journal-title":"J Rheumatol"},{"issue":"10","key":"10.1016\/j.jaad.2024.03.008_bib18","first-page":"1844","article-title":"Risk factors for early wound complications after orthopedic surgery for rheumatoid arthritis","volume":"22","author":"Escalante","year":"1995","journal-title":"J Rheumatol"},{"issue":"1","key":"10.1016\/j.jaad.2024.03.008_bib19","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1177\/107110070302400106","article-title":"The influence of rheumatoid chemotherapy, age, and presence of rheumatoid nodules on postoperative complications in rheumatoid foot and ankle surgery: analysis of 725 procedures in 104 patients [corrected]","volume":"24","author":"Bibbo","year":"2003","journal-title":"Foot Ankle Int"},{"issue":"5","key":"10.1016\/j.jaad.2024.03.008_bib20","doi-asserted-by":"crossref","first-page":"469","DOI":"10.3109\/s10165-011-0423-x","article-title":"Prosthetic joint infection after total hip or knee arthroplasty in rheumatoid arthritis patients treated with nonbiologic and biologic disease-modifying antirheumatic drugs","volume":"21","author":"Momohara","year":"2011","journal-title":"Mod Rheumatol"},{"issue":"3","key":"10.1016\/j.jaad.2024.03.008_bib21","doi-asserted-by":"crossref","first-page":"e430","DOI":"10.3928\/01477447-20160404-05","article-title":"Postoperative surgical infection after spinal surgery in rheumatoid arthritis","volume":"39","author":"Koyama","year":"2016","journal-title":"Orthopedics"},{"issue":"8","key":"10.1016\/j.jaad.2024.03.008_bib22","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1097\/MIB.0000000000000780","article-title":"Preoperative use of methotrexate and the risk of early postoperative complications in patients with inflammatory bowel disease","volume":"22","author":"Afzali","year":"2016","journal-title":"Inflamm Bowel Dis"},{"issue":"5","key":"10.1016\/j.jaad.2024.03.008_bib23","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1111\/j.1572-0241.2004.04148.x","article-title":"Early postoperative complications are not increased in patients with Crohn\u2019s disease treated perioperatively with infliximab or immunosuppressive therapy","volume":"99","author":"Colombel","year":"2004","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"10.1016\/j.jaad.2024.03.008_bib24","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s00384-006-0168-8","article-title":"Should ileoanal pouch surgery be staged for patients with mucosal ulcerative colitis on immunosuppressives?","volume":"22","author":"Zmora","year":"2007","journal-title":"Int J Colorectal Dis"},{"issue":"1","key":"10.1016\/j.jaad.2024.03.008_bib25","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/01.MIB.0000437497.07181.05","article-title":"Rescue therapy with cyclosporine or infliximab is not associated with an increased risk for postoperative complications in patients hospitalized for severe steroid-refractory ulcerative colitis","volume":"20","author":"Nelson","year":"2014","journal-title":"Inflamm Bowel Dis"},{"issue":"8","key":"10.1016\/j.jaad.2024.03.008_bib26","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1111\/codi.15702","article-title":"Perioperative safety of tofacitinib in surgical ulcerative colitis patients","volume":"23","author":"Lightner","year":"2021","journal-title":"Colorectal Dis"},{"issue":"4 Pt 2","key":"10.1016\/j.jaad.2024.03.008_bib27","first-page":"667","article-title":"Effect of acitretin on wound healing in organ transplant recipients","volume":"30","author":"Tan","year":"2004","journal-title":"Dermatol Surg"},{"issue":"4","key":"10.1016\/j.jaad.2024.03.008_bib28","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/j.jaad.2018.11.057","article-title":"Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with biologics","volume":"80","author":"Menter","year":"2019","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2024.03.008_bib29","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1093\/rheumatology\/key207","article-title":"The British Society for Rheumatology biologic DMARD safety guidelines in inflammatory arthritis-executive summary","volume":"58","author":"Holroyd","year":"2019","journal-title":"Rheumatology (Oxford)"},{"issue":"3","key":"10.1016\/j.jaad.2024.03.008_bib30","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1111\/bjd.15665","article-title":"British Association of Dermatologists guidelines for biologic therapy for psoriasis 2017","volume":"177","author":"Smith","year":"2017","journal-title":"Br J Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2024.03.008_bib31","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/j.jfma.2020.08.026","article-title":"Recommendations for psoriatic arthritis management: a joint position paper of the Taiwan Rheumatology Association and the Taiwanese Association for Psoriasis and Skin Immunology","volume":"120","author":"Tsai","year":"2021","journal-title":"J Formos Med Assoc"},{"issue":"3","key":"10.1016\/j.jaad.2024.03.008_bib32","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1007\/s00393-021-01140-x","article-title":"Perioperative management of treatment of patients with inflammatory rheumatic diseases: updated recommendations of the German Society of Rheumatology","volume":"81","author":"Albrecht","year":"2022","journal-title":"Z Rheumatol"},{"issue":"9","key":"10.1016\/j.jaad.2024.03.008_bib33","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1002\/acr.24893","article-title":"2022 American College of Rheumatology\/American Association of Hip and Knee Surgeons guideline for the perioperative management of antirheumatic medication in patients with rheumatic diseases undergoing elective total hip or total knee arthroplasty","volume":"74","author":"Goodman","year":"2022","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"3","key":"10.1016\/j.jaad.2024.03.008_bib34","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/1346-8138.15196","article-title":"Japanese guidance for use of biologics for psoriasis (the 2019 version)","volume":"47","author":"Saeki","year":"2020","journal-title":"J Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2024.03.008_bib35","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.jbspin.2013.09.001","article-title":"Recommendations for using TNF\u03b1 antagonists and French Clinical Practice Guidelines endorsed by the French National Authority for Health","volume":"80","author":"Go\u00ebb","year":"2013","journal-title":"Joint Bone Spine"},{"issue":"9","key":"10.1016\/j.jaad.2024.03.008_bib36","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1002\/art.42140","article-title":"2022 American College of Rheumatology\/American Association of Hip and Knee Surgeons guideline for the perioperative management of antirheumatic medication in patients with rheumatic diseases undergoing elective total hip or total knee arthroplasty","volume":"74","author":"Goodman","year":"2022","journal-title":"Arthritis Rheumatol"},{"issue":"4","key":"10.1016\/j.jaad.2024.03.008_bib40","doi-asserted-by":"crossref","first-page":"597","DOI":"10.2165\/00003495-199243040-00010","article-title":"Acitretin: a review of its pharmacology and therapeutic use","volume":"43","author":"Pilkington","year":"1992","journal-title":"Drugs"},{"issue":"1","key":"10.1016\/j.jaad.2024.03.008_bib41","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/jdv.12997","article-title":"The risk of post-operative complications in psoriasis and psoriatic arthritis patients on biologic therapy undergoing surgical procedures","volume":"30","author":"Bakkour","year":"2016","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"Suppl 1","key":"10.1016\/j.jaad.2024.03.008_bib42","first-page":"S24","article-title":"Management of patients with psoriasis treated with biological drugs needing a surgical treatment","volume":"75","author":"Fabiano","year":"2014","journal-title":"Drug Dev Res"},{"issue":"1","key":"10.1016\/j.jaad.2024.03.008_bib43","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.jaad.2009.04.039","article-title":"Perioperative use of\u00a0anti-tumor necrosis factor-alfa agents","volume":"62","author":"Reinstadler","year":"2010","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2024.03.008_bib44","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1124\/pr.57.2.3","article-title":"Low-dose methotrexate: a mainstay in the treatment of rheumatoid arthritis","volume":"57","author":"Cronstein","year":"2005","journal-title":"Pharmacol Rev"},{"issue":"9","key":"10.1016\/j.jaad.2024.03.008_bib45","doi-asserted-by":"crossref","first-page":"957","DOI":"10.2217\/imt.15.63","article-title":"Targeting IL-17 with ixekizumab in patients with psoriasis","volume":"7","author":"Dyring-Andersen","year":"2015","journal-title":"Immunotherapy"},{"issue":"12","key":"10.1016\/j.jaad.2024.03.008_bib46","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1111\/1346-8138.12668","article-title":"Secukinumab efficacy and safety in Japanese patients with moderate-to-severe plaque psoriasis: subanalysis from ERASURE, a randomized, placebo-controlled, phase 3 study","volume":"41","author":"Ohtsuki","year":"2014","journal-title":"J Dermatol"},{"issue":"Suppl 1","key":"10.1016\/j.jaad.2024.03.008_bib47","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1007\/s40259-013-0064-z","article-title":"Pegylation of biological molecules and potential benefits: pharmacological properties of certolizumab pegol","volume":"28","author":"Pasut","year":"2014","journal-title":"BioDrugs"},{"issue":"2","key":"10.1016\/j.jaad.2024.03.008_bib48","doi-asserted-by":"crossref","first-page":"374","DOI":"10.2215\/CJN.03791106","article-title":"Therapeutic monitoring of calcineurin inhibitors for the nephrologist","volume":"2","author":"Schiff","year":"2007","journal-title":"Clin J Am Soc Nephrol"},{"issue":"5","key":"10.1016\/j.jaad.2024.03.008_bib49","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1111\/j.1365-2133.2009.09505.x","article-title":"British Association of Dermatologists\u2019 guidelines for biologic interventions for psoriasis 2009","volume":"161","author":"Smith","year":"2009","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2024.03.008_bib50","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.clinthera.2011.11.015","article-title":"Golimumab pharmacokinetics after repeated subcutaneous and intravenous administrations in patients with rheumatoid arthritis and the effect of concomitant methotrexate: an open-label, randomized study","volume":"34","author":"Zhuang","year":"2012","journal-title":"Clin Ther"},{"issue":"2","key":"10.1016\/j.jaad.2024.03.008_bib51","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1177\/247553031016a00205","article-title":"How long does the benefit of biologics last? An update on time to relapse and potential for rebound of biologic agents for psoriasis","volume":"16","author":"Kamaria","year":"2010","journal-title":"Psoriasis Forum"},{"issue":"5","key":"10.1016\/j.jaad.2024.03.008_bib52","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1177\/107110070402500510","article-title":"Infectious and healing complications after elective orthopaedic foot and ankle surgery during tumor necrosis factor-alpha inhibition therapy","volume":"25","author":"Bibbo","year":"2004","journal-title":"Foot Ankle Int"},{"issue":"2","key":"10.1016\/j.jaad.2024.03.008_bib53","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1136\/annrheumdis-2017-212339","article-title":"Predictors of revision, prosthetic joint infection and mortality following total hip or total knee arthroplasty in patients with rheumatoid arthritis: a nationwide cohort study using Danish healthcare registers","volume":"77","author":"Cordtz","year":"2018","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.jaad.2024.03.008_bib54","first-page":"689","article-title":"Risk factors for surgical site infections and other complications in elective surgery in patients with rheumatoid arthritis with special attention for anti-tumor necrosis factor: a large retrospective study","volume":"34","author":"den Broeder","year":"2007","journal-title":"J Rheumatol"},{"issue":"2","key":"10.1016\/j.jaad.2024.03.008_bib55","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/art.21841","article-title":"Tumor necrosis factor inhibitor therapy and risk of serious postoperative orthopedic infection in rheumatoid arthritis","volume":"55","author":"Giles","year":"2006","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.jaad.2024.03.008_bib56","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1756-185X.2010.01579.x","article-title":"Clinical factors related to the efficacy and complications of orthopedic surgery for rheumatoid arthritis with infliximab","volume":"14","author":"Hayata","year":"2011","journal-title":"Int J Rheum Dis"},{"issue":"5","key":"10.1016\/j.jaad.2024.03.008_bib57","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s10067-009-1346-1","article-title":"Influences of anti-tumour necrosis factor agents on postoperative recovery in patients with rheumatoid arthritis","volume":"29","author":"Hirano","year":"2010","journal-title":"Clin Rheumatol"},{"issue":"5","key":"10.1016\/j.jaad.2024.03.008_bib58","doi-asserted-by":"crossref","first-page":"617","DOI":"10.3899\/jrheum.121171","article-title":"Patterns and associated risk of perioperative use of anti-tumor necrosis factor in patients with rheumatoid arthritis undergoing total knee replacement","volume":"40","author":"Johnson","year":"2013","journal-title":"J Rheumatol"},{"issue":"2","key":"10.1016\/j.jaad.2024.03.008_bib59","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1093\/rheumatology\/kep376","article-title":"Complications and features after joint surgery in rheumatoid arthritis patients treated with tumour necrosis factor-alpha blockers: perioperative interruption of tumour necrosis factor-alpha blockers decreases complications?","volume":"49","author":"Kawakami","year":"2010","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"10.1016\/j.jaad.2024.03.008_bib60","doi-asserted-by":"crossref","first-page":"844","DOI":"10.3109\/s10165-012-0612-2","article-title":"Perioperative complications in elective surgery in patients with rheumatoid arthritis treated with biologics","volume":"22","author":"Kubota","year":"2012","journal-title":"Mod Rheumatol"},{"issue":"3","key":"10.1016\/j.jaad.2024.03.008_bib61","first-page":"430","article-title":"Complication rates of 127 surgical procedures performed in rheumatic patients receiving tumor necrosis factor alpha blockers","volume":"25","author":"Ruyssen-Witrand","year":"2007","journal-title":"Clin Exp Rheumatol"},{"issue":"12","key":"10.1016\/j.jaad.2024.03.008_bib62","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1002\/acr.22077","article-title":"Infection risk after orthopedic surgery in patients with inflammatory rheumatic diseases treated with immunosuppressive drugs","volume":"65","author":"Scherrer","year":"2013","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"4","key":"10.1016\/j.jaad.2024.03.008_bib63","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1136\/ard.2004.028365","article-title":"Tumour necrosis factor alpha antagonists and early postoperative complications in patients with inflammatory joint disease undergoing elective orthopaedic surgery","volume":"64","author":"Talwalkar","year":"2005","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"10.1016\/j.jaad.2024.03.008_bib64","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1136\/ard.2005.037762","article-title":"Surgery in patients receiving anti-tumour necrosis factor alpha treatment in rheumatoid arthritis: an observational study on 50 surgical procedures","volume":"64","author":"Wendling","year":"2005","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.jaad.2024.03.008_bib65","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1136\/gutjnl-2011-301495","article-title":"Preoperative biological therapy and short-term outcomes of abdominal surgery in patients with inflammatory bowel disease","volume":"62","author":"Waterman","year":"2013","journal-title":"Gut"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962224004973?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962224004973?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,26]],"date-time":"2024-07-26T15:23:35Z","timestamp":1722007415000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962224004973"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":85,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["S0190962224004973"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2024.03.008","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Full Guidelines\u2014From the Medical Board of the National Psoriasis Foundation: Perioperative management of systemic immunomodulatory agents in patients with psoriasis and psoriatic arthritis","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2024.03.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 by the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}